SYNACT PHARMA ApS is a Danish APS based in Holte, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2012, the company has 7 employees and reported a gross profit of -DKK 53.2m in its latest annual filing.
Selskabets formål er at udvikle lægemidler og dermed relateret virksomhed samt enhver aktivitet, der efter direktionens skøn står i forbindelse hermed.
In its most recent annual report (2025), SYNACT PHARMA ApS reported a gross profit of -DKK 53.2m. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 59.8m.
At the end of 2025, equity financed 63.4% of the balance sheet, and current assets covered short-term debt 2.2 times.
Frequently asked questions
What is the CVR number of SYNACT PHARMA ApS?
SYNACT PHARMA ApS is registered with CVR / Virk under CVR 34459975.
What is the gross profit of SYNACT PHARMA ApS?
SYNACT PHARMA ApS reported a gross profit of -DKK 53.2m in 2025.
How many employees does SYNACT PHARMA ApS have?
SYNACT PHARMA ApS employs 7 people as of the latest annual report.
Who is the CEO of SYNACT PHARMA ApS?
Jeppe Øvli Øvlesen is the CEO of SYNACT PHARMA ApS, in role since 2024.
Where is SYNACT PHARMA ApS headquartered?
SYNACT PHARMA ApS's registered address is Dronninggårds Alle 136.
